Showing results (151-160 of 687) with videos related to
Sort By:
Pageof 69
Clinical Pharmacology and Therapeutics|October 1, 1976
Amobarbital--a probe of hepatic drug oxidation in manT Inaba, B K Tang, L Endrenyi, et al.Molecular and Cellular Biology|March 1, 1997
Cell transformation mediated by homodimeric E2A-HLF transcription factorsT Inukai, T Inaba, T Yoshihara, et al.Clinical Pharmacology and Therapeutics|May 1, 1977
A case of deficiency of N-hydroxylation of amobarbitalW Kalow, D Kadar, T Inaba, et al.Biomedical Mass Spectrometry|October 1, 1982
Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometryB K Tang, H Uchino, T Inaba, et al.Molecular and Cellular Biology|September 19, 1998
The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLFT Inukai, T Inaba, S Ikushima, et al.Clinical Pharmacology and Therapeutics|January 1, 1982
Sparteine metabolism in Canadian CaucasiansA Vinks, T Inaba, S V Otton, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenaseT Inaba, M Jurima, W A Mahon, et al.Clinical Pharmacology and Therapeutics|November 1, 1978
Distinctive patterns of amobarbital metabolitesW Kalow, B K Tang, D Kadar, et al.Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1978
Enzyme induction following a single dose of amobarbital in dogsP A Reilly, T Inaba, D Kadar, et al.Progress in Clinical and Biological Research|January 1, 1990
Photoradiation methods for purging autologous bone marrow graftsS Gulati, J Atzpodien, R M Lemoli, et al.Pageof 69